Showing results (101-110 of 199) with videos related to

Sort By:
Pageof 20
International Journal of Dermatology|December 10, 2025
Clinicopathologic Features and Outcomes of Actinic Keratosis and Skin Cancer After Hematopoietic Stem Cell TransplantationMiguel Mansilla-Polo, Juan Montoro, Javier López-Davia, et al.
Cancers|June 10, 2023
Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in SpainJavier de la Rubia, Rafael Alonso, María Esther Clavero, et al.
Haematologica|November 8, 2011
Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable diseaseLaura Rosiñol, Ramón García-Sanz, Juan José Lahuerta, et al.
Blood|July 10, 2008
A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myelomaLaura Rosiñol, José Antonio Pérez-Simón, Anna Sureda, et al.
Transplantation and Cellular Therapy|July 6, 2025
Incidence and Risk Factors of Skin Cancer and Preneoplastic Lesions after Autologous and Allogeneic Hematopoietic Cell TransplantationMiguel Mansilla-Polo, Juan Montoro, Javier López-Davia, et al.
Transplantation and Cellular Therapy|September 14, 2025
Bacterial Bloodstream Infections After Hematopoietic Cell Transplantation With Post-Transplant CyclophosphamidePedro Chorão, Santiago de Cossio, Paula Muñoz-Brell, et al.
The Lancet. Oncology|February 5, 2021
Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working GroupEvangelos Terpos, Elena Zamagni, Suzanne Lentzsch, et al.
Bone Marrow Transplantation|April 24, 2025
Cytokine release syndrome: implications for transplant outcomes in haploidentical and HLA-matched HSCT using PTCyRafael Benavente, Juan Montoro, Aitana Balaguer-Roselló, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2009
Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantationPau Montesinos, Jaime Sanz, Susana Cantero, et al.
American Journal of Cancer Research|October 18, 2021
Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatmentAlfredo Minguela, María A Vasco-Mogorrón, José A Campillo, et al.
Pageof 20